What are the next steps for a 32-year-old female with a normal Pap (Papanicolau) smear but positive for Human Papillomavirus (HPV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of 32-Year-Old Female with Normal Pap and Positive HPV Test

For a 32-year-old female with a normal Pap smear but positive HPV test, the recommended next step is to repeat co-testing (Pap and HPV test) in 12 months. 1

Rationale and Management Algorithm

The presence of HPV with normal cytology represents a common clinical scenario that requires appropriate follow-up due to the risk of developing cervical intraepithelial neoplasia (CIN) or cancer over time.

Initial Assessment

  • Normal Pap smear with positive HPV indicates HPV infection without current cytological abnormalities
  • At age 32, this patient falls into the age group (≥30 years) where specific management protocols apply
  • The risk of developing CIN3 or cancer within 10 years for women with normal cytology but positive HPV test is approximately 21% in women over 30 2

Management Steps

  1. Repeat co-testing (Pap and HPV test) in 12 months 1

    • This is the preferred approach for women with normal cytology but positive HPV test
    • Allows time to determine if the HPV infection will clear spontaneously
  2. Follow-up based on 12-month results:

    • If HPV test becomes negative and cytology remains normal: Return to routine screening 1
    • If HPV test remains positive OR cytology shows ASC-US or greater: Refer for colposcopy 3, 1
  3. Colposcopy indications:

    • Two consecutive positive HPV tests (even with normal cytology)
    • Any cytological abnormality on follow-up testing

Important Considerations

Risk Assessment

  • HPV infection is often transient, with most infections clearing spontaneously within 1-2 years 4, 5
  • However, persistent HPV infection is the primary risk factor for developing cervical cancer 4
  • The 10-year risk of CIN3+ in women with normal cytology but positive HPV test is significant (13.6-21.2%) 2

Common Pitfalls to Avoid

  1. Immediate colposcopy is not indicated

    • For women with normal Pap and positive HPV, immediate colposcopy is not recommended as the first step
    • Exception: If the HPV test specifically identifies types 16 or 18, colposcopy would be indicated 3
  2. Avoid under-follow-up

    • Simply returning to routine screening without follow-up testing is inappropriate due to the increased risk of developing cervical abnormalities 6
    • All women with a positive HPV test require follow-up, even with normal cytology
  3. Avoid over-treatment

    • No treatment is indicated at this stage without histological evidence of CIN
    • Diagnostic excisional procedures are not recommended without histologically diagnosed CIN 2/3 1

HPV Type Considerations

If HPV genotyping was performed:

  • HPV 16 or 18 positive: Consider immediate colposcopy due to higher risk of progression 3
  • Other high-risk HPV types: Follow the 12-month co-testing protocol 3, 1

By following this evidence-based approach, the risk of developing cervical cancer can be minimized while avoiding unnecessary procedures for transient HPV infections that may resolve spontaneously.

References

Guideline

Cervical Cancer Screening and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Overview of Human Papillomavirus Infection.

Infectious disorders drug targets, 2024

Research

HPV: diagnosis, prevention, and treatment.

Clinical obstetrics and gynecology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.